<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460358</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Myocarditis Associated with COVID-19 Vaccination.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101193</ELocationID><Abstract><AbstractText>Myocarditis after the COVID-19 vaccine is one of the important adverse events following immunization, observed mainly after mRNA-based vaccines. Importantly, post-vaccination myocarditis was less common than myocarditis after SARS-CoV-2 infection, as it was scored at 19.7 per 1,000,000 doses and 2.76 per 1000 infections. Predominantly, its course was benign and, compared with the myocarditis after COVID-19 infection, significantly fewer patients developed heart failure or died among patients with post-vaccination myocarditis. The group at highest risk of myocarditis related to COVID-19 vaccination were young males who received a second dose of an mRNA vaccine. It was observed that, among mRNA vaccines, specifically mRNA-1273 was associated with a higher risk of myocarditis. The mechanism underlying myocarditis after COVID-19 vaccination is still under investigation and certain processes are being considered. Currently, some follow-up assessments of patients who developed vaccine-induced myocarditis are available and suggest a favorable prognosis. The aim of this review is to discuss the most recent data on myocarditis after COVID-19 vaccination considering its epidemiology, clinical presentation, diagnosis, management, relative risk of myocarditis compared with SARS-CoV-2 infection, potential underlying mechanism, and follow-up data of patients who developed post-vaccination myocarditis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Florek</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0002-0256-2421</Identifier><AffiliationInfo><Affiliation>Student Scientific Club of Transplantology and Advanced Therapies of Heart Failure, Institute of Heart Diseases, Faculty of Medicine, Wroclaw Medical University, 50-369 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokolski</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Heart Diseases, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Diseases, University Hospital, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2019-nCoV vaccine mRNA-1273</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">mRNA vaccines</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460358</ArticleId><ArticleId IdType="pmc">PMC11512328</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101193</ArticleId><ArticleId IdType="pii">vaccines12101193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ammirati E., Moslehi J.J. Diagnosis and treatment of acute myocarditis. JAMA. 2023;329:1098. doi: 10.1001/jama.2023.3371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.3371</ArticleId><ArticleId IdType="pubmed">37014337</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L.S., Cooper L.T., Kerneis M., Funck-Brentano C., Silvain J., Brechot N., Hekimian G., Ammirati E., Ben M’barek B., Redheuil A., et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat. Commun. 2022;13:25. doi: 10.1038/s41467-021-27631-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27631-8</ArticleId><ArticleId IdType="pmc">PMC8748719</ArticleId><ArticleId IdType="pubmed">35013204</ArticleId></ArticleIdList></Reference><Reference><Citation>Brociek E., Tymińska A., Giordani A.S., Caforio A.L.P., Wojnicz R., Grabowski M., Ozierański K. Myocarditis: Etiology, pathogenesis, and their implications in clinical practice. Biology. 2023;12:874. doi: 10.3390/biology12060874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12060874</ArticleId><ArticleId IdType="pmc">PMC10295542</ArticleId><ArticleId IdType="pubmed">37372158</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabior A., Tymińska A., Pawlak A., Giordani A., Caforio A., Grabowski M., Ozierański K. Advances in myocarditis management in the light of the latest research and recent guidelines of the European Society of Cardiology. Cardiol. J. 2024;31:342–351. doi: 10.5603/cj.95175.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/cj.95175</ArticleId><ArticleId IdType="pmc">PMC11076022</ArticleId><ArticleId IdType="pubmed">38247433</ArticleId></ArticleIdList></Reference><Reference><Citation>Monath T.P., Frey S.E. Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis. Vaccine. 2009;27:1645–1650. doi: 10.1016/j.vaccine.2008.10.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.10.084</ArticleId><ArticleId IdType="pubmed">19022322</ArticleId></ArticleIdList></Reference><Reference><Citation>Engler R.J.M., Montgomery J.R., Spooner C.E., Nelson M.R., Collins L.C., Ryan M.A., Chu C.S., Atwood J.E., Hulten E.A., Rutt A.A., et al. Myocarditis and pericarditis recovery following smallpox vaccine 2002–2016: A comparative observational cohort study in the military health system. PLoS ONE. 2023;18:e0283988. doi: 10.1371/journal.pone.0283988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0283988</ArticleId><ArticleId IdType="pmc">PMC10166549</ArticleId><ArticleId IdType="pubmed">37155666</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar K., Subramanyam S., Del Rio-Pertuz G., Sethi P., Argueta-Sosa E. Cardiac Adverse Events after Vaccination—A Systematic Review. Vaccines. 2022;10:700. doi: 10.3390/vaccines10050700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050700</ArticleId><ArticleId IdType="pmc">PMC9143985</ArticleId><ArticleId IdType="pubmed">35632455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Feng L., Li Y., Lowe S., Guo Z., Bentley R., Xie C., Wu B., Xie P., Xia W., et al. A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am. J. Prev. Med. 2023;64:275–284. doi: 10.1016/j.amepre.2022.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2022.09.002</ArticleId><ArticleId IdType="pmc">PMC9510095</ArticleId><ArticleId IdType="pubmed">36266115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling R.R., Ramanathan K., Tan F.L., Tai B.C., Somani J., Fisher D., MacLaren G. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: A systematic review and meta-analysis. Lancet Respir. Med. 2022;10:679–688. doi: 10.1016/S2213-2600(22)00059-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00059-5</ArticleId><ArticleId IdType="pmc">PMC9000914</ArticleId><ArticleId IdType="pubmed">35421376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishisaka Y., Watanabe A., Aikawa T., Kanaoka K., Takagi H., Wiley J., Yasuhara J., Kuno T. Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis. Int. J. Cardiol. 2024;395:131401. doi: 10.1016/j.ijcard.2023.131401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2023.131401</ArticleId><ArticleId IdType="pubmed">37774926</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Beetler D.J., Di Florio D.N., Musigk N., Heidecker B., Cooper L.T. COVID-19, myocarditis and pericarditis. Circ. Res. 2023;132:1302–1319. doi: 10.1161/CIRCRESAHA.123.321878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321878</ArticleId><ArticleId IdType="pmc">PMC10171304</ArticleId><ArticleId IdType="pubmed">37167363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaamika H., Muralidas D., Elumalai K. Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases. J. Taibah Univ. Med. Sci. 2023;18:1646–1661. doi: 10.1016/j.jtumed.2023.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtumed.2023.08.004</ArticleId><ArticleId IdType="pmc">PMC10507236</ArticleId><ArticleId IdType="pubmed">37732332</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina G., Khawaja U., Contreras R., Burdowski J. COVID VACCINE MYOCARDITIS WITH COMPLETE RECOVERY. J. Am. Coll. Cardiol. 2023;81:2626. doi: 10.1016/S0735-1097(23)03070-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(23)03070-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal V., Mukherjee D., Ang S.P., Kainth T., Naz S., Shrestha A.B., Agrawal V., Mitra S., Chia J.E., Jilma B., et al. COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature. Int. J. Cardiol. Heart Vasc. 2023;49:101280. doi: 10.1016/j.ijcha.2023.101280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2023.101280</ArticleId><ArticleId IdType="pmc">PMC10746454</ArticleId><ArticleId IdType="pubmed">38143781</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gier B., Van Asten L., Boere T.M., Van Roon A., Van Roekel C., Pijpers J., van Werkhoven C.H., Ende C.v.D., Hahné S.J., de Melker H.E., et al. Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022. Vaccine. 2023;41:4488–4496. doi: 10.1016/j.vaccine.2023.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.06.005</ArticleId><ArticleId IdType="pmc">PMC10247887</ArticleId><ArticleId IdType="pubmed">37328352</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiri T., Evans M., Talarico C.A., Morgan A.R., Mussad M., Buck P.O., McEwan P., Strain W.D. Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example. Vaccines. 2021;9:1180. doi: 10.3390/vaccines9101180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101180</ArticleId><ArticleId IdType="pmc">PMC8537561</ArticleId><ArticleId IdType="pubmed">34696288</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. COVID-19: Vaccines have saved at least 1.4 million lives in Europe, WHO reports. BMJ. 2024;384:q125. doi: 10.1136/bmj.q125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.q125</ArticleId><ArticleId IdType="pubmed">38233071</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins Coronavirus Resource Center  Vaccine Research &amp; Development—Johns Hopkins Coronavirus Resource Center.  [(accessed on 4 May 2024)].  Available online:  https://coronavirus.jhu.edu/vaccines/timeline.</Citation></Reference><Reference><Citation>Tanveer S., Rowhani-Farid A., Hong K., Jefferson T., Doshi P. Transparency of COVID-19 vaccine trials: Decisions without data. BMJ Evid. Based Med. 2021;27:199–205. doi: 10.1136/bmjebm-2021-111735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2021-111735</ArticleId><ArticleId IdType="pubmed">34373256</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency (EMA)  COVID-19 Vaccines: Development, Evaluation, Approval and Monitoring|European Medicines Agency (EMA)  [(accessed on 4 May 2024)].  Available online:  https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-public-health-emergency-international-concern-2020-23/covid-19-vaccines-development-evaluation-approval-and-monitoring.</Citation></Reference><Reference><Citation>Bakos T., Mészáros T., Kozma G.T., Berényi P., Facskó R., Farkas H., Dézsi L., Heirman C., de Koker S., Schiffelers R., et al. MRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions. Int. J. Mol. Sci. 2024;25:3595. doi: 10.3390/ijms25073595.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25073595</ArticleId><ArticleId IdType="pmc">PMC11012056</ArticleId><ArticleId IdType="pubmed">38612407</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency  Authorised COVID-19 Vaccines. Published 1BC.  [(accessed on 7 July 2024)].  Available online:  https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines.</Citation></Reference><Reference><Citation>Our World in Data  COVID-19 Vaccine Doses Administered by Manufacturer.  [(accessed on 7 July 2024)].  Available online:  https://ourworldindata.org/grapher/covid-vaccine-doses-by-manufacturer.</Citation></Reference><Reference><Citation>European Medicines Agency  Vaxzevria (Previously COVID-19 Vaccine AstraZeneca)  [(accessed on 7 July 2024)].  Available online:  https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca.</Citation></Reference><Reference><Citation>European Medicines Agency  Jcovden (Previously COVID-19 Vaccine Janssen). Published 3 November 2021.  [(accessed on 7 July 2024)].  Available online:  https://www.ema.europa.eu/en/medicines/human/EPAR/jcovden-previously-covid-19-vaccine-janssen.</Citation></Reference><Reference><Citation>Li X., Burn E., Duarte-Salles T., Yin C., Reich C., Delmestri A., Verhamme K., Rijnbeek P., A Suchard M., Li K., et al. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different COVID-19 vaccines: International network cohort study from five European countries and the US. BMJ. 2022;379:e071594. doi: 10.1136/bmj-2022-071594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071594</ArticleId><ArticleId IdType="pmc">PMC9597610</ArticleId><ArticleId IdType="pubmed">36288813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S.K., Mohamed M.G., Essa R.A., Rashad E.A.A., Ibrahim P.K., Khdir A.A., Wsu Z.H. Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis. Diabetes Metab. Syndr. 2022;16:102513. doi: 10.1016/j.dsx.2022.102513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2022.102513</ArticleId><ArticleId IdType="pmc">PMC9135698</ArticleId><ArticleId IdType="pubmed">35660931</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlstad Ø., Hovi P., Husby A., Härkänen T., Selmer R.M., Pihlström N., Hansen J.V., Nohynek H., Gunnes N., Sundström A., et al. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiol. 2022;7:600. doi: 10.1001/jamacardio.2022.0583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.0583</ArticleId><ArticleId IdType="pmc">PMC9021987</ArticleId><ArticleId IdType="pubmed">35442390</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency  Bimervax.  [(accessed on 7 July 2024)].  Available online:  https://www.ema.europa.eu/en/medicines/human/EPAR/bimervax.</Citation></Reference><Reference><Citation>Borralleras C., Sanz J.C., Arrazola P., Hijón C.C., Eiros J.M., Fernández-Prada M., de Miguel Á.G., Masip G.M., Moraga-Llop F., Rodríguez D.O., et al. The PHH-1V HIPRA vaccine: A new tool in the vaccination strategy against COVID-19. Rev. Española Quimioter. 2023;36:507–515. doi: 10.37201/req/046.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/046.2023</ArticleId><ArticleId IdType="pmc">PMC10586735</ArticleId><ArticleId IdType="pubmed">37303137</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Kang L.Y., Liu J., Liu M. Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: An updated systematic review and meta-analysis. World J. Pediatr. 2023;19:1041–1054. doi: 10.1007/s12519-022-00680-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-022-00680-9</ArticleId><ArticleId IdType="pmc">PMC9890438</ArticleId><ArticleId IdType="pubmed">36723827</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster M.E., Shay D.K., Su J.R., Gee J., Creech C.B., Broder K.R., Edwards K., Soslow J.H., Dendy J.M., Schlaudecker E., et al. Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327:331. doi: 10.1001/jama.2021.24110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24110</ArticleId><ArticleId IdType="pmc">PMC8790664</ArticleId><ArticleId IdType="pubmed">35076665</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B.Q., Li H.B., Yang L.Q. Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years. Vaccine. 2023;41:4067–4080. doi: 10.1016/j.vaccine.2023.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.05.049</ArticleId><ArticleId IdType="pmc">PMC10201323</ArticleId><ArticleId IdType="pubmed">37246067</ArticleId></ArticleIdList></Reference><Reference><Citation>Das B.B., Kohli U., Ramachandran P., Nguyen H.H., Greil G., Hussain T., Tandon A., Kane C., Avula S., Duru C., et al. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J. Pediatr. 2021;238:26–32.e1. doi: 10.1016/j.jpeds.2021.07.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2021.07.044</ArticleId><ArticleId IdType="pmc">PMC8321962</ArticleId><ArticleId IdType="pubmed">34339728</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S., Dhaliwal J.S., Kumar N., Sakthivel H., Ahmed R., Verma R., Ramphul K. An epidemiological study of multisystem inflammatory syndrome in children (MIS-C) and young adults among COVID-19-positive patients—Data from National Inpatient Sample database. Reumatologia. 2024;62:214–216. doi: 10.5114/reum/189213.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum/189213</ArticleId><ArticleId IdType="pmc">PMC11267655</ArticleId><ArticleId IdType="pubmed">39055727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwikowska K.M., Moksud N., Tracewski P., Sokolski M., Szenborn L. Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland. Biomedicines. 2023;11:1251. doi: 10.3390/biomedicines11051251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11051251</ArticleId><ArticleId IdType="pmc">PMC10215748</ArticleId><ArticleId IdType="pubmed">37238922</ArticleId></ArticleIdList></Reference><Reference><Citation>Sık G., Inamlık A., Akçay N., Kesici S., Aygun F., Kendırlı T., Atay G., Sandal O., Varol F., Ozkaya P.Y., et al. Mortality risk factors among critically ill children with MIS-C in PICUs: A multicenter study. Pediatr. Res. 2023;94:730–737. doi: 10.1038/s41390-023-02518-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-023-02518-0</ArticleId><ArticleId IdType="pmc">PMC9946280</ArticleId><ArticleId IdType="pubmed">36813951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygaard U., Holm M., Hartling U.B., Glenthøj J., Schmidt L.S., Nordly S.B., Matthesen A.T., von Linstow M.-L., Espenhain L. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: A Danish nationwide prospective cohort study. Lancet Child Adolesc. Health. 2022;6:459–465. doi: 10.1016/S2352-4642(22)00100-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00100-6</ArticleId><ArticleId IdType="pmc">PMC9072929</ArticleId><ArticleId IdType="pubmed">35526537</ArticleId></ArticleIdList></Reference><Reference><Citation>Copland E., Patone M., Saatci D., Handunnetthi L., Hirst J., Hunt D.P.J., Mills N.L., Moss P., Sheikh A., Coupland C.A.C., et al. Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nat. Commun. 2024;15:3822. doi: 10.1038/s41467-024-47745-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-47745-z</ArticleId><ArticleId IdType="pmc">PMC11130197</ArticleId><ArticleId IdType="pubmed">38802362</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevathasan T., Kenny M.A., Gaul A.L., Paul J., Krause F.J., Lech S., Stadler G., Meyer A., Schreiber F., Fairweather D., et al. Sex and Age Characteristics in Acute or Chronic Myocarditis. JACC Adv. 2024;3:100857. doi: 10.1016/j.jacadv.2024.100857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.100857</ArticleId><ArticleId IdType="pmc">PMC11105794</ArticleId><ArticleId IdType="pubmed">38770230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Beetler D.J., Musigk N., Heidecker B., Lyle M.A., Cooper L.T., Bruno K.A. Sex and gender differences in myocarditis and dilated cardiomyopathy: An update. Front. Cardiovasc. Med. 2023;10:1129348. doi: 10.3389/fcvm.2023.1129348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1129348</ArticleId><ArticleId IdType="pmc">PMC10017519</ArticleId><ArticleId IdType="pubmed">36937911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.W.Y., Liu R.B., Huang C.Y., Li H.Y., Zhang Z.X., Li X.Z., Liu J.-L., Zhang C., Xiong X., Niu Y.-M. Global, regional, and national burdens of myocarditis, 1990–2019: Systematic analysis from GBD 2019. BMC Public Health. 2023;23:714. doi: 10.1186/s12889-023-15539-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15539-5</ArticleId><ArticleId IdType="pmc">PMC10116728</ArticleId><ArticleId IdType="pubmed">37076853</ArticleId></ArticleIdList></Reference><Reference><Citation>Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Myocarditis.  [(accessed on 5 May 2024)].  Available online:  https://www.escardio.org/Working-groups/Working-Group-on-Myocardial-and-Pericardial-Diseases/Publications/Paper-of-the-Month/Current-state-of-knowledge-on-aetiology-diagnosis-management-and-therapy-of-m.</Citation></Reference><Reference><Citation>Ferreira V.M., Schulz-Menger J., Holmvang G., Kramer C.M., Carbone I., Sechtem U., Kindermann I., Gutberlet M., Cooper L.T., Liu P., et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation. J. Am. Coll. Cardiol. 2018;72:3158–3176. doi: 10.1016/j.jacc.2018.09.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Doeblin P., Kelle S. Going after COVID-19 myocarditis. Eur. Heart J. Cardiovasc. Imaging. 2021;22:852–854. doi: 10.1093/ehjci/jeab097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeab097</ArticleId><ArticleId IdType="pmc">PMC8194973</ArticleId><ArticleId IdType="pubmed">34080005</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidecker B., Dagan N., Balicer R., Eriksson U., Rosano G., Coats A., Tschöpe C., Kelle S., Poland G.A., Frustaci A., et al. Myocarditis following COVID-19 vaccine: Incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. Eur. J. Heart Fail. 2022;24:2000–2018. doi: 10.1002/ejhf.2669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2669</ArticleId><ArticleId IdType="pmc">PMC9538893</ArticleId><ArticleId IdType="pubmed">36065751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolska J.M., Kurcz J., Kosmala W. Every rose has its thorns—Acute myocarditis following COVID-19 vaccination. Kardiol. Pol. 2021;79:1153–1154. doi: 10.33963/KP.a2021.0075.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.a2021.0075</ArticleId><ArticleId IdType="pubmed">34331307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wu T., Zhang C., Zhang Y., Liu Z., Wang Y. Clinically suspected lethal viral myocarditis combined with encephalitis: A COVID-19 vaccine complication. ESC Heart Fail. 2022;10:1422–1425. doi: 10.1002/ehf2.14229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14229</ArticleId><ArticleId IdType="pmc">PMC9877651</ArticleId><ArticleId IdType="pubmed">36347824</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsukjai A., Theerasuwipakorn N., Tumkosit M., Chattranukulchai P., Srichomkwun P., Prechawat S. Concomitant myocarditis and painless thyroiditis after AstraZeneca coronavirus disease 2019 vaccination: A case report. J. Med. Case Rep. 2022;16:212. doi: 10.1186/s13256-022-03438-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03438-z</ArticleId><ArticleId IdType="pmc">PMC9112634</ArticleId><ArticleId IdType="pubmed">35581666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Kamat I., Hotez P.J. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144:471–484. doi: 10.1161/CIRCULATIONAHA.121.056135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056135</ArticleId><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>JCPSP|Journal of College of Physicians and Surgeons Pakistan.  [(accessed on 7 July 2024)].  Available online:  https://www.jcpsp.pk/article-detail/pcardiac-troponini-a-biomarker-for-predicting-covidinduced-myocardial-damage-prognosisorp.</Citation></Reference><Reference><Citation>Manno E.C., Amodio D., Cotugno N., Rossetti C., Giancotta C., Santilli V., Zangari P., Rotulo G.A., Villani A., Giglioni E., et al. Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination. Pediatr. Infect. Dis. J. 2022;42:166–171. doi: 10.1097/INF.0000000000003762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003762</ArticleId><ArticleId IdType="pmc">PMC9838608</ArticleId><ArticleId IdType="pubmed">36638405</ArticleId></ArticleIdList></Reference><Reference><Citation>Pueyo P.P., Ruberte E.G., Ordás J.G., Blanco L.M., Figal D.P., Moreira J.M.L., Barrado J.J.G., Calle D.G., Bonet L.A., Salinas G.L.A., et al. Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination. Clin. Res. Cardiol. 2023;113:223–234. doi: 10.1007/s00392-023-02225-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-023-02225-0</ArticleId><ArticleId IdType="pubmed">37368015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Horita N., Utsunomiya D. Imaging characteristics of myocarditis after mRNA-based COVID-19 vaccination: A meta-analysis. ESC Heart Fail. 2022;10:748–750. doi: 10.1002/ehf2.14236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14236</ArticleId><ArticleId IdType="pmc">PMC9871647</ArticleId><ArticleId IdType="pubmed">36404672</ArticleId></ArticleIdList></Reference><Reference><Citation>Samimisedeh P., Afshar E.J., Tayebi A., Rastad H. Post-acute midterm follow-up cardiac MRI findings and clinical outcomes in patients with COVID-19 vaccine-associated myocarditis: A comprehensive systematic review and meta-analysis. Infect. Dis. 2023;56:193–205. doi: 10.1080/23744235.2023.2286289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2023.2286289</ArticleId><ArticleId IdType="pubmed">38000007</ArticleId></ArticleIdList></Reference><Reference><Citation>Salah H.M., Mehta J.L. COVID-19 vaccine and myocarditis. Am. J. Cardiol. 2021;157:146–148. doi: 10.1016/j.amjcard.2021.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.07.009</ArticleId><ArticleId IdType="pmc">PMC8272967</ArticleId><ArticleId IdType="pubmed">34399967</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou O.H.I., Mui J., Chung C.T., Radford D., Ranjithkumar S., Evbayekha E., Nam R., Pay L., Satti D.I., Garcia-Zamora S., et al. COVID-19 vaccination and carditis in children and adolescents: A systematic review and meta-analysis. Clin. Res. Cardiol. 2022;111:1161–1173. doi: 10.1007/s00392-022-02070-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-022-02070-7</ArticleId><ArticleId IdType="pmc">PMC9361966</ArticleId><ArticleId IdType="pubmed">35906423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulscher N., Hodkinson R., Makis W., McCullough P.A. Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis. ESC Heart Fail. 2024 doi: 10.1002/ehf2.14680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14680</ArticleId><ArticleId IdType="pubmed">38221509</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.D., Mall G., Westphal J.G., Weingärtner O., Möbius-Winkler S., Schulze P.C. Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection. ESC Heart Fail. 2021;8:4710–4714. doi: 10.1002/ehf2.13613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13613</ArticleId><ArticleId IdType="pmc">PMC8652969</ArticleId><ArticleId IdType="pubmed">34536056</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaka T., Koitabashi N., Ishibashi Y., Aihara K., Takama N., Ohyama Y., Yokoyama T., Kaneko Y. Acute myocarditis associated with COVID-19 vaccination: A case report. J. Cardiol. Cases. 2021;25:285–288. doi: 10.1016/j.jccase.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jccase.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8639400</ArticleId><ArticleId IdType="pubmed">34876937</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C., Domke L.M., Hartmann L., Stenzinger A., Longerich T., Schirmacher P. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin. Res. Cardiol. 2022;112:431–440. doi: 10.1007/s00392-022-02129-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-022-02129-5</ArticleId><ArticleId IdType="pmc">PMC9702955</ArticleId><ArticleId IdType="pubmed">36436002</ArticleId></ArticleIdList></Reference><Reference><Citation>De Boer H.H., Crawford N.W., Parsons S. Commentary on: “Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination” by C. Schwab et al. Clin. Res. Cardiol. 2023;113:353–355. doi: 10.1007/s00392-023-02197-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-023-02197-1</ArticleId><ArticleId IdType="pmc">PMC10126533</ArticleId><ArticleId IdType="pubmed">37097464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiblboeck D., Klingel K., Genger M., Traxler S., Braunsteiner N., Steinwender C., Kellermair J. Myocarditis following mRNA COVID-19 vaccination: Call for endomyocardial biopsy. ESC Heart Fail. 2022;9:1996–2002. doi: 10.1002/ehf2.13791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13791</ArticleId><ArticleId IdType="pmc">PMC9065833</ArticleId><ArticleId IdType="pubmed">35194974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.H., Na J.Y., Yang J.H., Moon S.H., Kim S.H., Jung J.J., Cha H.-J., Ahn J.-H., Park Y.-W., Cho S.-Y., et al. Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19. Medicina. 2022;58:449. doi: 10.3390/medicina58030449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58030449</ArticleId><ArticleId IdType="pmc">PMC8950462</ArticleId><ArticleId IdType="pubmed">35334625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameratunga R., Woon S.T., Sheppard M.N., Garland J., Ondruschka B., Wong C.X., Stewart R.A.H., Tatley M., Stables S.R., Tse R.D. First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): An Extremely Rare Idiosyncratic Hypersensitivity Reaction. J. Clin. Immunol. 2022;42:441–447. doi: 10.1007/s10875-021-01187-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01187-0</ArticleId><ArticleId IdType="pmc">PMC8720536</ArticleId><ArticleId IdType="pubmed">34978002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch V.G., Schallhorn S., Zwadlo C., Diekmann J., Länger F., Jonigk D.D., Kempf T., Schultheiss H., Bauersachs J. Giant cell myocarditis after first dose of BNT162b2—A case report. Eur. J. Heart Fail. 2022;24:1319–1322. doi: 10.1002/ejhf.2590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2590</ArticleId><ArticleId IdType="pmc">PMC9350328</ArticleId><ArticleId IdType="pubmed">35733299</ArticleId></ArticleIdList></Reference><Reference><Citation>Guglin M.E., Etuk A., Shah C., Ilonze O.J. Fulminant myocarditis and cardiogenic Shock Following COVID-19 Infection versus COVID-19 Vaccination: A Systematic literature review. J. Clin. Med. 2023;12:1849. doi: 10.3390/jcm12051849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12051849</ArticleId><ArticleId IdType="pmc">PMC10003085</ArticleId><ArticleId IdType="pubmed">36902636</ArticleId></ArticleIdList></Reference><Reference><Citation>Saputra P.B.T., Kurniawan R.B., Trilistyoati D., Farabi M.J.A., Susilo H., Alsagaff M.Y., Oktaviono Y.H., Sutanto H., Gusnanto A., Wungu C.D.K. Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases. Biomol. Biomed. 2023;23:546–567. doi: 10.17305/bb.2022.8779.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bb.2022.8779</ArticleId><ArticleId IdType="pmc">PMC10351100</ArticleId><ArticleId IdType="pubmed">36803547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura M., Hashimoto T., Noda E., Ishikawa Y., Ishikita A., Fujino T., Matsushima S., Ide T., Kinugawa S., Nagaoka K., et al. Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support. ESC Heart Fail. 2022;9:2732–2737. doi: 10.1002/ehf2.13962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13962</ArticleId><ArticleId IdType="pmc">PMC9288782</ArticleId><ArticleId IdType="pubmed">35616026</ArticleId></ArticleIdList></Reference><Reference><Citation>Janga C., Patel T., Hennawi H.A., Atam S., Shah S., Naeem I., Memon R., Haas D. Delayed presentation of biopsy-proven eosinophilic myocarditis following COVID-19 mRNA vaccine. Glob. Cardiol. Sci. Pract. 2023;2023:e202310. doi: 10.21542/gcsp.2023.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.21542/gcsp.2023.10</ArticleId><ArticleId IdType="pmc">PMC10282781</ArticleId><ArticleId IdType="pubmed">37351099</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka K., Matsuo T., Ishimatsu T., Fukae A., Hamamoto T., Oku K., Ito M. A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman. Clin. Case Rep. 2022;10:e6161. doi: 10.1002/ccr3.6161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.6161</ArticleId><ArticleId IdType="pmc">PMC9445258</ArticleId><ArticleId IdType="pubmed">36093466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano H., Motokawa T., Kurohama H., Okano S., Akashi R., Yonekura T., Ikeda S., Izumikawa K., Maemura K. Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination. Intern. Med. 2022;61:2319–2325. doi: 10.2169/internalmedicine.9800-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.9800-22</ArticleId><ArticleId IdType="pmc">PMC9424077</ArticleId><ArticleId IdType="pubmed">35650138</ArticleId></ArticleIdList></Reference><Reference><Citation>Munjal J.S., Flores S.M., Yousuf H., Gupta V., Munjal R.S., Anamika F., Mendpara V., Shah P., Jain R. COVID- 19 vaccine-induced myocarditis. J. Community Hosp. Intern. Med. Perspect. 2023;13:9. doi: 10.55729/2000-9666.1229.</Citation><ArticleIdList><ArticleId IdType="doi">10.55729/2000-9666.1229</ArticleId><ArticleId IdType="pmc">PMC10589044</ArticleId><ArticleId IdType="pubmed">37868673</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.Z., Janus S., Franklin S., Figueredo V., Baqi A., Alvarez R. COVID-19 Vaccination-Induced cardiomyopathy requiring permanent left ventricular assist device. Cureus. 2022;14:e24477. doi: 10.7759/cureus.24477.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24477</ArticleId><ArticleId IdType="pmc">PMC9132740</ArticleId><ArticleId IdType="pubmed">35651464</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghashzadeh F., Shafaghi S., Dorudinia A., Naji S.A., Marjani M., Amin A., Mohamadifar A., Noorali S., Kashani B.S. Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: Case report. ESC Heart Fail. 2022;9:1483–1486. doi: 10.1002/ehf2.13821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13821</ArticleId><ArticleId IdType="pmc">PMC8934948</ArticleId><ArticleId IdType="pubmed">35106967</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Kim K.H. COVID-19 Vaccination-Related myocarditis: What we learned from our experience and what we need to do in the future. Korean Circ. J. 2024;54:295–310. doi: 10.4070/kcj.2024.0065.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2024.0065</ArticleId><ArticleId IdType="pmc">PMC11169908</ArticleId><ArticleId IdType="pubmed">38654456</ArticleId></ArticleIdList></Reference><Reference><Citation>Voleti N., Reddy S.P., Ssentongo P. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Front. Cardiovasc. Med. 2022;9:951314. doi: 10.3389/fcvm.2022.951314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.951314</ArticleId><ArticleId IdType="pmc">PMC9467278</ArticleId><ArticleId IdType="pubmed">36105535</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami A., Krewski D., Farhat N., Mattison D., Wilson K., Gravel C.A., Farrell P.J., Crispo J.A.G., Haddad N., Perez-Lloret S., et al. Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: A systematic review and meta-analysis. BMJ Open. 2023;13:e065687. doi: 10.1136/bmjopen-2022-065687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065687</ArticleId><ArticleId IdType="pmc">PMC10314577</ArticleId><ArticleId IdType="pubmed">37339840</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A., et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation. 2022;146:743–754. doi: 10.1161/CIRCULATIONAHA.122.059970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059970</ArticleId><ArticleId IdType="pmc">PMC9439633</ArticleId><ArticleId IdType="pubmed">35993236</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2021;28:410–422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Buergin N., Lopez-Ayala P., Hirsiger J.R., Mueller P., Median D., Glarner N., Rumora K., Herrmann T., Koechlin L., Haaf P., et al. Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination. Eur. J. Heart Fail. 2023;25:1871–1881. doi: 10.1002/ejhf.2978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2978</ArticleId><ArticleId IdType="pubmed">37470105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills N.L., Patone M., Hippisley-Cox J. Response by Mills et al. Regarding Article, “Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex”. Circulation. 2023;147:e655–e656. doi: 10.1161/CIRCULATIONAHA.122.063394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.063394</ArticleId><ArticleId IdType="pubmed">36877769</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoninfante A., Andeweg A., Genov G., Cavaleri M. Myocarditis associated with COVID-19 vaccination. NPJ Vaccines. 2024;9:122. doi: 10.1038/s41541-024-00893-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-024-00893-1</ArticleId><ArticleId IdType="pmc">PMC11213864</ArticleId><ArticleId IdType="pubmed">38942751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi S., Kalantari Y., Shokri S., Fallahpour M., Nafissi N., Goodarzi A., Valizadeh R. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2—21 years old: A Systematic Review and Meta-analysis. J. Clin. Virol. 2022;153:105196. doi: 10.1016/j.jcv.2022.105196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2022.105196</ArticleId><ArticleId IdType="pmc">PMC9162782</ArticleId><ArticleId IdType="pubmed">35716417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang H.W., Kwan M.Y.W., Chua G.T., Tsao S.S.L., Wong J.S.C., Tung K.T.S., Chan G.C.F., To K.K.W., Wong I.C.K., Leung W.H., et al. The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccination. Med. 2024;5:335–347.e3. doi: 10.1016/j.medj.2024.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2024.02.008</ArticleId><ArticleId IdType="pubmed">38521068</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B. Shedding light on mechanisms of myocarditis with COVID-19 mRNA vaccines. Circulation. 2023;147:877–880. doi: 10.1161/CIRCULATIONAHA.123.063396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.063396</ArticleId><ArticleId IdType="pmc">PMC10010664</ArticleId><ArticleId IdType="pubmed">36794591</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin. Immunol. 2020;217:108480. doi: 10.1016/j.clim.2020.108480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108480</ArticleId><ArticleId IdType="pmc">PMC7246018</ArticleId><ArticleId IdType="pubmed">32461193</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Swank Z., Bartsch Y.C., Burns M.D., Kane A., Boribong B.P., Davis J.P., Loiselle M., Novak T., Senussi Y., et al. Circulating spike protein detected in Post–COVID-19 mRNA vaccine myocarditis. Circulation. 2023;147:867–876. doi: 10.1161/CIRCULATIONAHA.122.061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.061025</ArticleId><ArticleId IdType="pmc">PMC10010667</ArticleId><ArticleId IdType="pubmed">36597886</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K., Fujii T., Mori K., Tamimoto R., Nagamatsu H., Murakami T., Cho Y., Goto S., Mori H. Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination. J. Clin. Med. 2023;12:1421. doi: 10.3390/jcm12041421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041421</ArticleId><ArticleId IdType="pmc">PMC9961568</ArticleId><ArticleId IdType="pubmed">36835957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B.C., Castells M.C. Utilizing biologics in drug desensitization. Curr. Allergy Asthma Rep. 2022;23:1–11. doi: 10.1007/s11882-022-01052-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-022-01052-z</ArticleId><ArticleId IdType="pmc">PMC9707161</ArticleId><ArticleId IdType="pubmed">36445652</ArticleId></ArticleIdList></Reference><Reference><Citation>Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Lopatin Y.M. Impact of heart failure on all-cause mortality in COVID-19: Findings from the Eurasian International Registry. ESC Heart Fail. 2022;10:1013–1024. doi: 10.1002/ehf2.14243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14243</ArticleId><ArticleId IdType="pmc">PMC9878039</ArticleId><ArticleId IdType="pubmed">36519220</ArticleId></ArticleIdList></Reference><Reference><Citation>Talib N., Fronza M., Marschner C.A., Thavendiranathan P., Karur G.R., Hanneman K. Cardiovascular Magnetic Resonance Imaging and Clinical Follow-Up in Patients with Clinically Suspected Myocarditis after COVID-19 Vaccination. J. Cardiovasc. Magn. Reson. 2024;26:101036. doi: 10.1016/j.jocmr.2024.101036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocmr.2024.101036</ArticleId><ArticleId IdType="pmc">PMC11004989</ArticleId><ArticleId IdType="pubmed">38479457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kracalik I., Oster M.E., Broder K.R., Cortese M.M., Glover M., Shields K., Creech C.B., Romanson B., Novosad S., Soslow J., et al. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: A follow-up surveillance study. Lancet Child Adolesc. Health. 2022;6:788–798. doi: 10.1016/S2352-4642(22)00244-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00244-9</ArticleId><ArticleId IdType="pmc">PMC9555956</ArticleId><ArticleId IdType="pubmed">36152650</ArticleId></ArticleIdList></Reference><Reference><Citation>Husby A., Gulseth H.L., Hovi P., Hansen J.V., Pihlström N., Gunnes N., Härkänen T., Dahl J., Karlstad Ø., Heliö T., et al. Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: Population based cohort study. BMJ Med. 2023;2:e000373. doi: 10.1136/bmjmed-2022-000373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000373</ArticleId><ArticleId IdType="pmc">PMC9978676</ArticleId><ArticleId IdType="pubmed">36936260</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroth D., Garg R., Bocova X., Hansmann J., Haass M., Yan A., Fernando C., Chacko B., Oikonomou A., White J., et al. Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry) Front. Cardiovasc. Med. 2023;10:1204232. doi: 10.3389/fcvm.2023.1204232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1204232</ArticleId><ArticleId IdType="pmc">PMC10321411</ArticleId><ArticleId IdType="pubmed">37416926</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzuoli A., Metra M., Collins S.P., Adamo M., Ambrosy A.P., Antohi L.E., Ben Gal T., Farmakis D., Gustafsson F., Hill L., et al. Heart failure during the COVID-19 pandemic: Clinical, diagnostic, management, and organizational dilemmas. ESC Heart Fail. 2022;9:3713–3736. doi: 10.1002/ehf2.14118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14118</ArticleId><ArticleId IdType="pmc">PMC9773739</ArticleId><ArticleId IdType="pubmed">36111511</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishita T., Takada D., Shin J., Higuchi T., Kunisawa S., Fushimi K., Imanaka Y. Effects of the COVID-19 pandemic on heart failure hospitalizations in Japan: Interrupted time series analysis. ESC Heart Fail. 2021;9:31–38. doi: 10.1002/ehf2.13744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13744</ArticleId><ArticleId IdType="pmc">PMC8788142</ArticleId><ArticleId IdType="pubmed">34913269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubica J., Ostrowska M., Stolarek W., Kasprzak M., Grzelakowska K., Kryś J., Kubica A., Adamski P., Podhajski P., Navarese E.P., et al. Impact of COVID-19 pandemic on acute heart failure admissions and mortality: A multicentre study (COV-HF-SIRIO 6 study) ESC Heart Fail. 2021;9:721–728. doi: 10.1002/ehf2.13680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13680</ArticleId><ArticleId IdType="pmc">PMC8652676</ArticleId><ArticleId IdType="pubmed">34786869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolski M., Trenson S., Sokolska J.M., D’Amario D., Meyer P., Poku N.K., Biering-Sørensen T., Lassen M.C.H., Skaarup K.G., Barge-Caballero E., et al. Heart failure in COVID-19: The multicentre, multinational PCHF-COVICAV registry. ESC Heart Fail. 2021;8:4955–4967. doi: 10.1002/ehf2.13549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13549</ArticleId><ArticleId IdType="pmc">PMC8653014</ArticleId><ArticleId IdType="pubmed">34533287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolski M., Reszka K., Suchocki T., Adamik B., Doroszko A., Drobnik J., Gorka-Dynysiewicz J., Jedrzejczyk M., Kaliszewski K., Kilis-Pstrusinska K., et al. History of heart failure in patients hospitalized due to COVID-19: Relevant factor of In-Hospital complications and All-Cause mortality up to six months. J. Clin. Med. 2022;11:241. doi: 10.3390/jcm11010241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11010241</ArticleId><ArticleId IdType="pmc">PMC8746048</ArticleId><ArticleId IdType="pubmed">35011982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno R.R., Wernly B., Wolff G., Fjølner J., Artigas A., Pinto B.B., Schefold J.C., Kindgen-Milles D., Baldia P.H., Kelm M., et al. Association of chronic heart failure with mortality in old intensive care patients suffering from COVID-19. ESC Heart Fail. 2022;9:1756–1765. doi: 10.1002/ehf2.13854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13854</ArticleId><ArticleId IdType="pmc">PMC9065875</ArticleId><ArticleId IdType="pubmed">35274490</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>